[1] Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 [J]. Histopathology, 2000, 36(1): 69-86.
[2] Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project [J]. Blood, 2009, 113(17): 3931-3937.
[3] Tse E, Kwong YL. How I treat NK/T-cell lymphomas [J]. Blood, 2013, 121(25): 4997-5005.
[4] Sun J, Yang Q, Lu Z, et al. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification [J]. Am J Clin Pathol, 2012, 138(3): 429-434.
[5] Tababi S, Kharrat S, Sellami M, et al. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases [J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2012, 129(3): 141-147.
[6] Li YX, Liu QF, Fang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma [J]. Clin Cancer Res, 2009, 15(8): 2905-2912.
[7] Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research [J]. Hematology Am Soc Hematol Educ Program, 2009: 523-531.
[8] Sabattini E, Bacci F, Sagramoso C, et al. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview [J]. Pathologica, 2010, 102(3): 83-87.
[9] Aniwan S, Rerknimitr R, Wisedopas N, et al. Colonic NK/T-cell lymphoma mimicking Crohn's disease[J]. Endoscopy, 2014, 46 (Suppl 1): E312-E313.
[10] 陈蕊, 漆学良, 雷浪, 等. 误诊为多发性硬化的原发中枢神经系统NK/T细胞淋巴瘤一例[J]. 中国神经免疫学和神经病学杂志, 2016, 23(2): 146-148.
[11] Ramakrishnan R, Donahue H, Garcia D, et al. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas [J]. PLoS One, 2011, 6(11): e27271.
[12] 郭鹏德, 鲜军舫, 陈光利, 等. 眼部淋巴瘤临床表现、病理及MRI/CT影像分析 [J]. 中华医学杂志, 2015, 95(11): 814-818.
[13] Dragan LR, Baron JM, Stern S, et al. Solid facial edema preceding a diagnosis of retro-orbital B-cell lymphoma [J]. J Am Acad Dermatol, 2000, 42(5 Pt 2): 872-874.
[14] Gelb AB, van de Rijn M, Regula DP Jr, et al. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia [J]. Hum Pathol, 1994, 25(9): 953-960.
[15] Wang L, Xia ZJ, Huang HQ, et al. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients [J]. Int J Hematol, 2012, 96(5): 617-623.
[16] Guo Y, Lu JJ, Ma X, et al. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy [J]. Oral Oncol, 2008, 44(1): 23-30.
[17] Yamaguchi M, Kwong YL, Kim WS, et al. Phase Ⅱ study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-cell tumor study group study[J]. J Clin Oncol, 2011, 29(33): 4410-4416.
[18] 黄岩, 林桐榆, 吴秋良, 等. 111例T细胞非霍奇金淋巴瘤的临床预后分析 [J]. 癌症, 2005, 24(4): 470-474.
[19] Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study [J]. J Clin Oncol, 2006, 24(4): 612-618.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	CHEN Hua, LI Jing, LUO Mei. Effect of salidroside on the growth of oral squamous cell carcinoma cells through regulating NRF2/KEAP1 pathway [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(5): 424-429.
[2]	HE Ran, HOU De-qiang. Correlation between perioperative symptom clusters and quality of life in patients with oral and maxillofacial neoplasms [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(5): 446-454.
[3]	WANG Xue, ZHANG Ning. Clinical observation of 810 nm diode laser in the treatment of salivary gland mucocele [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(5): 459-462.
[4]	HUANG Xin, GUO Zheng-jian, BAO Gang, ZHANG Ting-ting. Peripheral ameloblastoma of gingival soft tissue: a case report [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(5): 510-512.
[5]	MAO Chuan-qing, LIN Zhi-lin, LIU Yu, CAI Zhi-yu, CHEN Wei-hui. Epidermoid cysts in free forearm flaps of the buccal region： a case report [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(5): 518-520.
[6]	ZHAO Hui, SHU Xin, ZHANG Fan, REN Wei-wei, LIU Jiao, ZHU Zhu. Comprehensive bioinformatics analysis combined with experimental validation to screen biomarkers for head and neck squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(4): 329-338.
[7]	GUO Yi-bo, LI Chen-yao, FAN Qi, JI Tong, REN Zhen-hu. Head and neck cancer therapy-induced lymphedema: clinical factors and prognostic analysis [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(4): 360-364.
[8]	HUANG Can, LUO Tao, SUN Yu. The predictive value of modified frailty assessment tool for postoperative complications in elderly patients undergoing flap reconstruction with oral squamous cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(4): 373-377.
[9]	GUO Yi-fei, ZHANG Yong-hong, REN Zhen-hu. Diagnosis and treatment of head and neck sarcoma [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(4): 404-408.
[10]	LI Chen-xi, FANG Chang, GONG Zhong-cheng, SHAO Bo. Case report of chondromyxofibroma involving the overall structure of the temporomandibular joint: surgical resection and reconstruction [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(4): 409-412.
[11]	XU Chen, MA Li-juan, SHI Yao, WEN Yu-zhen, SONG Yong-hai, CHE Zong-gang. Inflammatory myofibroblastic tumor of parotid gland: a case report and literature review [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(4): 413-416.
[12]	XI Qi, GAO Wan-peng, LI Huan, ZHAO Qi, WANG Jun, WEI Jian-hua, YANG Xin-jie, YANG Zi-hui. Screening and validation of miRNAs differentially expressed by exosomes of tumor-associated macrophages in microenvironment of salivary gland adenoid cystic carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(3): 209-215.
[13]	WANG Rui-jie, MA Hai-long, ZHANG Zhi-yuan. Expression and significance of histone lactylation modifications in head and neck tumors [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(3): 228-232.
[14]	HONG Lei, CHEN Wei-liang. Risk factor analysis of postoperative venous thromboembolism in elderly patients with oral cancer [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(3): 233-238.
[15]	WANG Min, QIAN Jia-jun, XUE Jun-qing, GU Ting, HU Yu-hua, CHEN Ying, XIA Rong-hui. Analysis of NR4A3 gene rearrangement and NOR-1 protein expression in salivary gland acinic cell carcinoma [J]. China Journal of Oral and Maxillofacial Surgery, 2024, 22(3): 249-254.